15:24 uur 20-07-2021

Crown Bioscience investeert in commercieel leiderschap

Nieuwe vicepresident voor bedrijfsontwikkeling in Noord-Amerika en Europa

Crown Bioscience, een JSR Life Sciences onderneming, kondigt vandaag de benoeming aan van Alex Slater als Vice President voor Business Development, Noord-Amerika en Europa. In deze rol zal de heer Slater verantwoordelijk zijn voor de voortdurende groei binnen de bestaande dienstenportefeuille van het bedrijf en voor het leggen van de basis voor de uitbreiding van nieuwe diensten.

SAN DIEGO-(BUSINESS WIRE)- De investering in extra leiderschap binnen de afdeling commerciële en strategische ontwikkeling van CrownBio weerspiegelt de toenemende breedte en wetenschappelijke diepgang van het aanbod van het bedrijf, en de waardering voor de behoefte aan op maat gemaakte oplossingen op zowel account- als gebiedsniveau. De nieuwe functie is een aanvulling op de recente uitbreidingen van CrownBio’s afdelingen Marketing, Product Management en Wetenschappelijke betrokkenheid en maakt deel uit van het bredere streven van het bedrijf om ervoor te zorgen dat de ervaring van hun klanten toonaangevend is in de branche.

Crown Bioscience Invests in Commercial Leadership

New Vice President to lead North America and Europe Business Development

Crown Bioscience, a JSR Life Sciences company, today announces the appointment of Alex Slater as Vice President of Business Development, North America and Europe. In this role, Mr Slater will be responsible for the continued growth within the Company’s existing services portfolio and for setting the foundation for the expansion of new services.

SAN DIEGO–(BUSINESS WIRE)– The investment in additional leadership within CrownBio’s commercial and strategic development division reflects the increasing breadth and scientific depth of the company’s offerings, and an appreciation of the need for tailored solutions at both an account and territory level. The new position will complement recent expansions in CrownBio’s Marketing, Product Management and Scientific Engagement departments, and is part of the company’s broader commitment to ensure that their customers’ experience is industry-leading.

Commenting on the appointment, Mike Prosser, Senior Vice President, Commercial and Strategic Development, said, “I am delighted to welcome Alex to the team, and to fill another crucial role for the company, during an exciting phase of CrownBio’s growth. Alex’s extensive leadership experience in the CRO industry, encompassing multiple phases of drug discovery and development, will be invaluable to us as we evolve our teams in line with market opportunity.”

Mr. Slater joins CrownBio from Biocellvia, where he was VP of the business development function. In previous roles, he has served as Global VP for Business Development at Eurofins and held multiple sales leadership positions at Covance/LabCorp.

“During my interview process I was impressed by the strength of the leadership team at CrownBio, their commitment to innovation and the value they place in their customers’ experience,” commented Alex. “Further, the business development team already in place at CrownBio is highly motivated and professional and in my capacity as VP of Business Development I look forward to working with them to accelerate the organization’s future expansion.”

About Crown Bioscience

Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development service company providing translational platforms to advance oncology, immuno-oncology and inflammatory disorders. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

Find out more at: http://www.CrownBio.com

Contacts

Media Enquiries:
Louise Stenson

Crown Bioscience

pr@crownbio.com

Check out our twitter: @NewsNovumpr